Pharmaceutical

GSK pumps up to $800m for US manufacturing site upgrade

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

Oct 26, 2024 - 04:00
GSK pumps up to $800m for US manufacturing site upgrade
A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
Read the original article

Tags:

Previous Article

LEO’s Adbry demonstrates long-term efficacy in atopic dermatitis

Next Article

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Moderna cuts five programmes to save $1.1bn in R&D costs

Moderna cuts five programmes to save $1.1bn in R&D costs

Sep 14, 2024

STAT+: The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma

STAT+: The ADC hot streak continues: J&J to buy cancer ...

Jan 8, 2024

STAT+: Hospitals struggle to validate AI-generated clinical summaries. ‘It’s a bit chaotic’

STAT+: Hospitals struggle to validate AI-generated clin...

Mar 13, 2024